Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Summit plc
Summit plc
Activities:
Manufacturing
Ingredients
Research & Development
Infection Control
Pharmaceutical
X
LinkedIn
Trending Articles
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
ChargePoint invest in a single-use manufacturing facility to expand product line
The single-use manufacturing facility will become fully operational in June 2024, and will support the company's trio of liquid and powder transfer devices
COVID-19 still a significant risk for the immunocompromised, study finds
AstraZeneca's INFORM study highlights the persistent danger of COVID-19 for the immunocompromised despite the vaccination scheme
Broughton receives flexible scope ISO 17025 accreditation
New certification allows accreditation without prior approval
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Summit appoints Dr David Roblin as Chief Medical Officer
Roblin has been involved in the successful development of a number of important medicines in a range of therapy areas
Research & Development
Wellcome Trust awards Summit £4m to further develop C. Difficile antibiotic
Phase I trial to start by end of the year with results expected in first half of 2013
Research & Development
Summit agrees technology licence with Bristol-Myers Squibb
Summit will receive $100,000 fee for access to its Seglin technology
Manufacturing
Cambridge Major Labs supports Summit antibiotic project
The chemistry outsourcing partner will help develop Summit’s antibiotic for Clostridium difficile
Subscribe now